| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| let-7a | Paclitaxel | hepatocellular carcinoma | Resistant | Low | 18758960 | |
| let-7a | Paclitaxel | squamous carcinoma | Resistant | Low | 18758960 | |
| let-7d | Paclitaxel | oral cancer | Sensitive | Low | 21725603 | |
| let-7a | Paclitaxel | breast cancer | Sensitive | Low | 22808086 | |
| let-7i | Paclitaxel | ovarian carcinoma | Sensitive | Low | 22812695 | |
| let-7b | Paclitaxel | laryngeal cancer | Sensitive | High | 23826416 | |
| let-7i | Paclitaxel | lung cancer | Sensitive | High | 24157646 | |
| let-7 | Paclitaxel | ovarian cancer | Sensitive | Low | 24186202 | |
| let-7e | Paclitaxel | lung cancer | Sensitive | High | 24220856 | |
| let-7e | Paclitaxel | Cancer | Sensitive | High | 24220856 | |
| let-7a | Paclitaxel | lung adenocarcinoma | Sensitive | High | 24755562 | |
| let-7 | Paclitaxel | hepatocellular carcinoma | Associated | Low | 24970027 | |
| let-7b | Paclitaxel | breast cancer | Sensitive | High | 25137071 | |
| let-7 | Paclitaxel | KRAS mutation cancer | Sensitive | Low | 25946136 | |
| let-7g | Paclitaxel | lung adenocarcinoma | Sensitive | High | 26323677 |